Found: 30
Select item for more details and to access through your institution.
Integrins and p53 pathways in glioblastoma resistance to temozolomide.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00157
- By:
- Publication type:
- Article
Evaluation of the Cytotoxicity of Cationic Polymers on Glioblastoma Cancer Stem Cells.
- Published in:
- Journal of Functional Biomaterials, 2023, v. 14, n. 1, p. 17, doi. 10.3390/jfb14010017
- By:
- Publication type:
- Article
Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14101980
- By:
- Publication type:
- Article
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 9, p. 882, doi. 10.3390/ph14090882
- By:
- Publication type:
- Article
Glioblastoma Metabolism: Insights and Therapeutic Strategies.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9137, doi. 10.3390/ijms24119137
- By:
- Publication type:
- Article
Imidazoline Receptors and Cardiovascular Regulations.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 763, n. 1, p. 526, doi. 10.1111/j.1749-6632.1995.tb32446.x
- By:
- Publication type:
- Article
Antiidiotypic Antibodies as Tools to Study Imidazoline Receptors.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 763, n. 1, p. 140, doi. 10.1111/j.1749-6632.1995.tb32398.x
- By:
- Publication type:
- Article
Respective contributions of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
- Published in:
- British Journal of Pharmacology, 2001, v. 133, n. 2, p. 261, doi. 10.1038/sj.bjp.0704080
- By:
- Publication type:
- Article
IRAS Is an Anti-Apoptotic Protein.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1009, n. 1, p. 400, doi. 10.1196/annals.1304.054
- By:
- Publication type:
- Article
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1268, doi. 10.3390/cancers15041268
- By:
- Publication type:
- Article
Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5057, doi. 10.3390/cancers14205057
- By:
- Publication type:
- Article
Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1482, doi. 10.3390/cancers14061482
- By:
- Publication type:
- Article
Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 369, doi. 10.3390/cancers14020369
- By:
- Publication type:
- Article
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3038, doi. 10.3390/cancers13123038
- By:
- Publication type:
- Article
A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2252, doi. 10.3390/cancers13092252
- By:
- Publication type:
- Article
A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1795, doi. 10.3390/cancers13081795
- By:
- Publication type:
- Article
Hypoxia Inducible Factors' Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 979, doi. 10.3390/cancers12040979
- By:
- Publication type:
- Article
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric H3.3-Mutated Gliomas Recreate the Patient Tumor Complexity.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1875, doi. 10.3390/cancers11121875
- By:
- Publication type:
- Article
Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 692, doi. 10.3390/cancers11050692
- By:
- Publication type:
- Article
Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers.
- Published in:
- Cancers, 2017, v. 9, n. 6, p. 69, doi. 10.3390/cancers9060069
- By:
- Publication type:
- Article
Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer.
- Published in:
- ChemBioChem, 2021, v. 22, n. 7, p. 1151, doi. 10.1002/cbic.202000626
- By:
- Publication type:
- Article
HGG-23. GLUTAMINOLYSIS INVOLVEMENT AND ITS TARGETING IN PEDIATRIC HIGH GRADE GLIOMAS: A NEW WAY OF TREATMENT.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii91, doi. 10.1093/neuonc/noz036.117
- By:
- Publication type:
- Article
Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
- Published in:
- Cellular & Molecular Life Sciences, 2021, v. 78, n. 6, p. 2949, doi. 10.1007/s00018-020-03686-6
- By:
- Publication type:
- Article
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.
- Published in:
- Frontiers in Pharmacology, 2015, p. 1, doi. 10.3389/fphar.2015.00279
- By:
- Publication type:
- Article
Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70820-6
- By:
- Publication type:
- Article
Involvement of the TGFβ pathway in the regulation of α<sub>5</sub>β<sub>1</sub> integrins by caveolin-1 in human glioblastoma.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 3, p. 601, doi. 10.1002/ijc.26415
- By:
- Publication type:
- Article
α5β1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 5, p. 1240, doi. 10.1002/ijc.25187
- By:
- Publication type:
- Article
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 5, p. 733, doi. 10.3390/cells12050733
- By:
- Publication type:
- Article
Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 1998, doi. 10.3390/cells9091998
- By:
- Publication type:
- Article
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11178, doi. 10.3390/ijms241311178
- By:
- Publication type:
- Article